MedTrace Logo

Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population

NCT04224896 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 335

Last updated 2020-01-13

No results posted yet for this study

Summary

Narrow-Band Imaging (NBI) is as sensitive as Lugol chromoendoscopy to detect oesophageal squamous cell carcinoma (SCC) and appears more specific than Lugol chromoendoscopy in expert centres but its specificity in current practice is not known. This study aimed to prove the superiority of NBI specificity over Lugol chromoendoscopy to detect oesophageal SCC and high-grade dysplasia (HGD) in current practice (including tertiary care centres, local hospitals and private clinics).

Conditions

  • FRENCH STUDY

Interventions

DIAGNOSTIC_TEST

UPPER ENDOSCOPY

UPPER ENDOSCOPY

Sponsors & Collaborators

  • Hôpital Edouard Herriot

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-01
Primary Completion
2011-03-01
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04224896 on ClinicalTrials.gov